The chemical class designated as TMEM103 Activators encompasses a range of compounds identified based on their ability to influence cellular signalling pathways and processes associated with the biological function of TMEM103, a subunit of the Elongator complex. These activators are not directly interacting with TMEM103 but can modulate its activity through the indirect regulation of its environment and associated pathways. The Elongator complex, to which TMEM103 belongs, plays a critical role in several cellular processes, including but not limited to the modification of transfer RNAs, regulation of transcription, and the maintenance of neuronal health and plasticity. Consequently, any compound that can alter these processes can also modulate the activity of TMEM103.
The compounds classified as TMEM103 activators can have diverse mechanisms of action. Some may act as inhibitors of enzymes like histone deacetylases or DNA methyltransferases, thereby affecting chromatin structure and gene expression in a manner that can lead to enhanced TMEM103 function. Others may interact with key cellular signaling pathways such as mTOR, PI3K/AKT, or MAPK/ERK, which are implicated in protein synthesis and cellular growth and differentiation. By modulating these pathways, these compounds can affect the Elongator complex indirectly. Additionally, certain activators might influence the cell cycle and transcriptional regulation, thereby impacting the processes that depend on the proper function of TMEM103. The overall effect of these activators is to modulate the cellular context in which TMEM103 operates, leading to changes in its activity within its native cellular environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that leads to DNA demethylation and could possibly activate TMEM103 by inducing transcriptional changes affecting Elongator complex activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
A phosphodiesterase inhibitor that raises intracellular cAMP levels, which could possibly activate TMEM103 by influencing signaling pathways that the Elongator complex may interact with. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor known to affect protein synthesis and could possibly activate TMEM103 by modulating the Elongator complex's role in tRNA modification. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C activator that could possibly activate TMEM103 by modulating signal transduction pathways, potentially impacting the Elongator complex. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A signaling molecule that could possibly activate TMEM103 by regulating gene expression, which might impact Elongator complex function in transcriptional regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that could possibly activate TMEM103 by influencing gene expression patterns, affecting Elongator complex activity. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
A compound that binds to GC-rich DNA sequences, could possibly activate TMEM103 by regulating transcription of genes that the Elongator complex might act upon. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that could possibly activate TMEM103 by blocking the MAPK/ERK signaling pathway, affecting processes in which the Elongator complex is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could possibly activate TMEM103 by affecting the AKT signaling pathway, which might indirectly influence Elongator complex activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor that could possibly activate TMEM103 by impacting cell cycle regulation and transcription, processes where the Elongator complex may play a role. | ||||||